Search results
CDC: All Adults Should Be Tested for Hepatitis B at Least Once in Their Lifetime
Verywell Health via Yahoo News· 1 year agoThe Centers for Disease Control and Prevention has updated its guidance for hepatitis B testing. It...
Understanding If There’s a Cure for Hepatitis B
Verywell Health via Yahoo News· 2 years agoWhen news broke in 2014 that hepatitis C, a viral disease affecting the liver, could be cured thanks to a new class of direct-acting antiviral drugs,...
What Is a Monoclonal Antibody?
Verywell Health via Yahoo News· 1 year agoA Manufactured Immune Protein Used to Diagnose and Treat Diseases Space_Cat / Getty Images Medically reviewed by Kashif J. Piracha, MD A monoclonal...
Patient concerned after potentially exposed to viruses during procedure at Atrium
WSOC via Yahoo News· 2 years agoThere is another patient who was potentially exposed to HIV and Hepatitis B or C during a urology...
Vir Biotechnology, Inc. (NASDAQ:VIR) Q4 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 3 months agoVir Biotechnology, Inc. (NASDAQ:VIR) Q4 2023 Earnings Call Transcript February 22, 2024 Vir...
Vir Biotechnology (VIR) Up on Positive Data From HDV Study
Zacks via Yahoo Finance· 2 days agoVir Biotechnology (VIR) rises on upbeat data from its phase II study evaluating tobevibart and...
Q3 2023 Vir Biotechnology Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 7 months agoParticipants Marianne De Backer; CEO & Director; Vir Biotechnology, Inc. Phillip Pang; Executive VP, Chief Medical Officer & Interim Head of Research; Vir Biotechnology, Inc. Sasha Damouni Ellis ...
What Is Hepatitis A?
Health via Yahoo News· 1 year agoHepatitis A is a viral infection that affects the liver. The virus spreads through close contact with someone else who has hepatitis A or through consuming hepatitis A-contaminated food or water ...
VBI Vaccines Announces Cost Cutting Measures, Reverse Stock Split
Benzinga via Yahoo Finance· 1 year agoVBI Vaccines Inc (NASDAQ: VBIV) plans to focus concentrating on broadening access to VBI's...
Arbutus Biopharma Corporation (NASDAQ:ABUS) Q4 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 3 months agoArbutus Biopharma Corporation (NASDAQ:ABUS) Q4 2023 Earnings Call Transcript February 29, 2024...